Cortical and subcortical pathological burden and neuronal loss in an autopsy series of FTLD-TDP-type C.
TDP-43
behavioural variant frontotemporal dementia
frontotemporal lobar degeneration
primary progressive aphasia
Journal
Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537
Informations de publication
Date de publication:
29 04 2022
29 04 2022
Historique:
received:
07
06
2021
revised:
11
08
2021
accepted:
29
08
2021
pubmed:
18
12
2021
medline:
3
5
2022
entrez:
17
12
2021
Statut:
ppublish
Résumé
The TDP-43 type C pathological form of frontotemporal lobar degeneration is characterized by the presence of immunoreactive TDP-43 short and long dystrophic neurites, neuronal cytoplasmic inclusions, neuronal loss and gliosis and the absence of neuronal intranuclear inclusions. Frontotemporal lobar degeneration-TDP-type C cases are commonly associated with the semantic variant of primary progressive aphasia or behavioural variant frontotemporal dementia. Here, we provide detailed characterization of regional distributions of pathological TDP-43 and neuronal loss and gliosis in cortical and subcortical regions in 10 TDP-type C cases and investigate the relationship between inclusions and neuronal loss and gliosis. Specimens were obtained from the first 10 TDP-type C cases accessioned from the Northwestern Alzheimer's Disease Research Center (semantic variant of primary progressive aphasia, n = 7; behavioural variant frontotemporal dementia, n = 3). A total of 42 cortical (majority bilateral) and subcortical regions were immunostained with a phosphorylated TDP-43 antibody and/or stained with haematoxylin-eosin. Regions were evaluated for atrophy, and for long dystrophic neurites, short dystrophic neurites, neuronal cytoplasmic inclusions, and neuronal loss and gliosis using a semiquantitative 5-point scale. We calculated a 'neuron-to-inclusion' score (TDP-type C mean score - neuronal loss and gliosis mean score) for each region per case to assess the relationship between TDP-type C inclusions and neuronal loss and gliosis. Primary progressive aphasia cases demonstrated leftward asymmetry of cortical atrophy consistent with the aphasic phenotype. We also observed abundant inclusions and neurodegeneration in both cortical and subcortical regions, with certain subcortical regions emerging as particularly vulnerable to dystrophic neurites (e.g. amygdala, caudate and putamen). Interestingly, linear mixed models showed that regions with lowest TDP-type C pathology had high neuronal dropout, and conversely, regions with abundant pathology displayed relatively preserved neuronal densities (P < 0.05). This inverse relationship between the extent of TDP-positive inclusions and neuronal loss may reflect a process whereby inclusions disappear as their associated neurons are lost. Together, these findings offer insight into the putative substrates of neurodegeneration in unique dementia syndromes.
Identifiants
pubmed: 34919645
pii: 6468612
doi: 10.1093/brain/awab368
pmc: PMC9050539
doi:
Substances chimiques
DNA-Binding Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1069-1078Subventions
Organisme : NIA NIH HHS
ID : P30 AG013854
Pays : United States
Organisme : NIA NIH HHS
ID : K08 AG065463
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG077444
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072977
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG062566
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS085770
Pays : United States
Informations de copyright
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
Acta Neuropathol. 2009 Jan;117(1):45-53
pubmed: 18923836
Mol Psychiatry. 2019 Sep;24(9):1369-1382
pubmed: 30899091
Acta Neuropathol. 2020 Jan;139(1):83-98
pubmed: 31501924
Acta Neuropathol Commun. 2017 Sep 6;5(1):68
pubmed: 28877758
Acta Neuropathol. 2007 Jul;114(1):5-22
pubmed: 17579875
Neuroimage Clin. 2020;28:102369
pubmed: 32798912
J Neuropathol Exp Neurol. 2018 May 1;77(5):405-412
pubmed: 29584904
Front Neurol. 2015 Jul 01;6:147
pubmed: 26191038
Alzheimers Res Ther. 2016 Dec 5;8(1):52
pubmed: 27915998
Neurology. 2018 Jan 30;90(5):e396-e403
pubmed: 29305438
Arch Neurol. 2007 Oct;64(10):1449-54
pubmed: 17923628
N Engl J Med. 2003 Oct 16;349(16):1535-42
pubmed: 14561797
Arch Neurol. 2008 Feb;65(2):249-55
pubmed: 18268196
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Neurology. 2005 Feb 8;64(3):556-7
pubmed: 15699397
Brain. 2018 Jan 1;141(1):288-301
pubmed: 29228211
Acta Neuropathol. 2009 Sep;118(3):349-58
pubmed: 19455346
Neuropathology. 2013 Apr;33(2):122-33
pubmed: 22702520
Dement Neuropsychol. 2013 Jan 1;7(1):2-9
pubmed: 24707349
Prog Clin Biol Res. 1989;317:837-48
pubmed: 2557644
Am J Pathol. 2006 Oct;169(4):1343-52
pubmed: 17003490
Acta Neuropathol. 2020 Jan;139(1):27-43
pubmed: 31542807
Nat Rev Neurol. 2013 Dec;9(12):708-14
pubmed: 24217521
Ann Neurol. 2001 Apr;49(4):425-32
pubmed: 11310619
Neurobiol Aging. 1995 May-Jun;16(3):271-8; discussion 278-84
pubmed: 7566337
J Neuropathol Exp Neurol. 2017 Nov 1;76(11):957-968
pubmed: 29044416
Ann Neurol. 2018 Jun;83(6):1096-1104
pubmed: 29665116
Curr Opin Neurobiol. 2007 Oct;17(5):548-55
pubmed: 17936612
Dement Neurocogn Disord. 2016 Dec;15(4):93-102
pubmed: 30906349
Neurology. 2010 Dec 14;75(24):2204-11
pubmed: 21172843
Brain. 2009 Nov;132(Pt 11):2906-8
pubmed: 19861505
Brain. 2014 Apr;137(Pt 4):1176-92
pubmed: 24574501
Acta Neuropathol. 2008 Jan;115(1):123-31
pubmed: 18004574
Dement Geriatr Cogn Disord. 2013;35(1-2):34-50
pubmed: 23306166
J Neuropathol Exp Neurol. 2018 Jan 1;77(1):2-20
pubmed: 29186501
J Neurol. 1992 Apr;239(4):191-4
pubmed: 1597685
Acta Neuropathol. 2006 Nov;112(5):539-49
pubmed: 17021754
Ann Neurol. 1982 Jun;11(6):592-8
pubmed: 7114808
Neurology. 2014 Sep 23;83(13):1184-91
pubmed: 25165386
Acta Neuropathol. 2010 Jan;119(1):1-4
pubmed: 19924424
Acta Neuropathol. 2011 Jul;122(1):111-3
pubmed: 21644037
Brain Res. 1993 Jan 22;601(1-2):164-72
pubmed: 8431763
Alzheimers Res Ther. 2020 Mar 27;12(1):34
pubmed: 32220237
Brain. 2012 May;135(Pt 5):1554-65
pubmed: 22522938
Acta Neuropathol. 2017 Jul;134(1):65-78
pubmed: 28130640